Reflections on the Innovative Medicines Initiative
Related Experiment Video
Updated: Jun 2, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
1Innovative Medicines Initiative, B-1060 Brussels, Belgium. michel.goldman@imi.europa.eu
Abstract:
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public-private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Regulation
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinical Trials: Overview
